Literature DB >> 16809329

Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.

Mansour Mohamadzadeh1, Sadie S Coberley, Gene G Olinger, Warren V Kalina, Gordon Ruthel, Claudette L Fuller, Dana L Swenson, William D Pratt, Douglas B Kuhns, Alan L Schmaljohn.   

Abstract

Marburg virus (MARV) and Ebola virus (EBOV), members of the viral family Filoviridae, cause fatal hemorrhagic fevers in humans and nonhuman primates. High viral burden is coincident with inadequate adaptive immune responses and robust inflammatory responses, and virus-mediated dysregulation of early host defenses has been proposed. Recently, a novel class of innate receptors called the triggering receptors expressed in myeloid cells (TREM) has been discovered and shown to play an important role in innate inflammatory responses and sepsis. Here, we report that MARV and EBOV activate TREM-1 on human neutrophils, resulting in DAP12 phosphorylation, TREM-1 shedding, mobilization of intracellular calcium, secretion of proinflammatory cytokines, and phenotypic changes. A peptide specific to TREM-1 diminished the release of tumor necrosis factor alpha by filovirus-activated human neutrophils in vitro, and a soluble recombinant TREM-1 competitively inhibited the loss of cell surface TREM-1 that otherwise occurred on neutrophils exposed to filoviruses. These data imply direct activation of TREM-1 by filoviruses and also indicate that neutrophils may play a prominent role in the immune and inflammatory responses to filovirus infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809329      PMCID: PMC1489070          DOI: 10.1128/JVI.00543-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Proteolytic processing of Marburg virus glycoprotein.

Authors:  V E Volchkov; V A Volchkova; U Ströher; S Becker; O Dolnik; M Cieplik; W Garten; H D Klenk; H Feldmann
Journal:  Virology       Date:  2000-03-01       Impact factor: 3.616

2.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 3.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

4.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock.

Authors:  A Bouchon; F Facchetti; M A Weigand; M Colonna
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

5.  Early immune responses accompanying human asymptomatic Ebola infections.

Authors:  E M Leroy; S Baize; P Debre; J Lansoud-Soukate; E Mavoungou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

6.  Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Authors:  Siddhartha Mahanty; Karen Hutchinson; Sudhanshu Agarwal; Michael McRae; Pierre E Rollin; Bali Pulendran
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

Review 7.  Hemorrhagic fever viruses as biological weapons: medical and public health management.

Authors:  Luciana Borio; Thomas Inglesby; C J Peters; Alan L Schmaljohn; James M Hughes; Peter B Jahrling; Thomas Ksiazek; Karl M Johnson; Andrea Meyerhoff; Tara O'Toole; Michael S Ascher; John Bartlett; Joel G Breman; Edward M Eitzen; Margaret Hamburg; Jerry Hauer; D A Henderson; Richard T Johnson; Gigi Kwik; Marci Layton; Scott Lillibridge; Gary J Nabel; Michael T Osterholm; Trish M Perl; Philip Russell; Kevin Tonat
Journal:  JAMA       Date:  2002-05-08       Impact factor: 56.272

8.  Inflammatory responses in Ebola virus-infected patients.

Authors:  S Baize; E M Leroy; A J Georges; M-C Georges-Courbot; M Capron; I Bedjabaga; J Lansoud-Soukate; E Mavoungou
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

9.  Fibrinogen induces IL-8 synthesis in human neutrophils stimulated with formyl-methionyl-leucyl-phenylalanine or leukotriene B(4).

Authors:  D B Kuhns; E L Nelson; W G Alvord; J I Gallin
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

10.  Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.

Authors:  P Pushko; M Bray; G V Ludwig; M Parker; A Schmaljohn; A Sanchez; P B Jahrling; J F Smith
Journal:  Vaccine       Date:  2000-08-15       Impact factor: 3.641

View more
  39 in total

1.  Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection.

Authors:  Sarah E Belisle; Jennifer R Tisoncik; Marcus J Korth; Victoria S Carter; Sean C Proll; David E Swayne; Mary Pantin-Jackwood; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.

Authors:  Gimano D Amatngalim; Anastasia Nijnik; Pieter S Hiemstra; Robert E W Hancock
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

3.  Ebola virus and persistent chronic infection: when does replication cease?

Authors:  John V Forrester
Journal:  Ann Transl Med       Date:  2018-11

4.  Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.

Authors:  Adrián Lázaro-Frías; Sergio Gómez-Medina; Lucas Sánchez-Sampedro; Karl Ljungberg; Mart Ustav; Peter Liljeström; César Muñoz-Fontela; Mariano Esteban; Juan García-Arriaza
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

5.  TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine.

Authors:  Zhihong Yuan; Mansoor Syed; Dipti Panchal; Myungsoo Joo; Chetna Bedi; Sokbee Lim; Hayat Onyuksel; Israel Rubinstein; Marco Colonna; Ruxana T Sadikot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

6.  Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

Authors:  Osvaldo Martinez; Charalampos Valmas; Christopher F Basler
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

7.  Induction of triggering receptor expressed on myeloid cells (TREM-1) in airway epithelial cells by 1,25(OH)₂ vitamin D₃.

Authors:  Isaura Rigo; Laura McMahon; Puneet Dhawan; Sylvia Christakos; Sunghan Yim; Lisa K Ryan; Gill Diamond
Journal:  Innate Immun       Date:  2011-06-20       Impact factor: 2.680

Review 8.  Novel understanding of high mobility group box-1 in the immunopathogenesis of incisional hernias.

Authors:  Nicholas K Larsen; Matthew J Reilly; Finosh G Thankam; Robert J Fitzgibbons; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2019-04-25       Impact factor: 4.473

Review 9.  Microbial induction of vascular pathology in the CNS.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-18       Impact factor: 4.147

Review 10.  Triggering receptor expressed on myeloid cells and 5'adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target.

Authors:  Finosh G Thankam; Matthew F Dilisio; Kaitlin A Dougherty; Nicholas E Dietz; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-06-13       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.